Journal of dentistry · 2025
The prevalence of peri-implant mucositis and peri-implantitis based on the world workshop criteria: A systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Reis Isabella Neme Ribeiro Dos, Huamán-Mendoza Aldrin André, Ramadan Dania, Honório Heitor Marques, Naenni Nadja, Romito Giuseppe Alexandre, Holzhausen Marinella, Pannuti Claudio Mendes
Аннотация
OBJECTIVES: This systematic review and meta-analysis aimed to estimate the worldwide prevalence of peri-implant mucositis and peri-implantitis using the 2017 World Workshop criteria.
DATA AND SOURCES: A comprehensive electronic search was performed in MEDLINE/PubMed, SCOPUS, EMBASE, and Web of Science databases. Cross-sectional studies assessing the prevalence of peri-implant diseases according to the 2017 Classification of Periodontal and Peri-Implant Diseases and Conditions classification were included. The risk of bias was assessed according to the Joanna Briggs Institute Critical Appraisal tool for Studies Reporting Prevalence Data. A mixed-effects model meta-analysis was performed.
STUDY SELECTION: Twenty out of 1979 studies were included. The weighted mean prevalence of peri-implant mucositis was 63.0 % (CI: 57.6-68.2 %) at the patient level and 59.2 % (CI: 55.8-62.4 %) at the implant level. Peri-implantitis was observed in 25.0 % (CI: 21.1-29.3 %) of patients and 18.0 % (CI: 15.8-20.5 %) of implants. Subgroup analyses revealed significant differences in the prevalence of peri-implant mucositis and peri-implantitis across continents. In non-smokers, the implant-level prevalence of peri-implant mucositis and peri-implantitis was 38.2 % (CI: 33.4-43.2 %) and 5.2 % (CI: 3.6-7.5 %), respectively. The risk of bias was high in 50 %, moderate in 45 %, and low in 5 % of the studies.
CONCLUSIONS: Based on the 2017 World Workshop criteria, the prevalence of peri-implant diseases represents a significant and growing public health challenge. Our study demonstrated that approximately two in three adults with dental implants had peri-implant mucositis, and one in four had peri-implantitis.
CLINICAL SIGNIFICANCE: This study is the first to provide robust global prevalence estimates for peri-implant diseases based on standardized 2017 World Workshop criteria. The findings highlight the high worldwide prevalence of peri-implant diseases, emphasizing the need for uniform diagnostic protocols and targeted prevention and treatment strategies.
DATA AND SOURCES: A comprehensive electronic search was performed in MEDLINE/PubMed, SCOPUS, EMBASE, and Web of Science databases. Cross-sectional studies assessing the prevalence of peri-implant diseases according to the 2017 Classification of Periodontal and Peri-Implant Diseases and Conditions classification were included. The risk of bias was assessed according to the Joanna Briggs Institute Critical Appraisal tool for Studies Reporting Prevalence Data. A mixed-effects model meta-analysis was performed.
STUDY SELECTION: Twenty out of 1979 studies were included. The weighted mean prevalence of peri-implant mucositis was 63.0 % (CI: 57.6-68.2 %) at the patient level and 59.2 % (CI: 55.8-62.4 %) at the implant level. Peri-implantitis was observed in 25.0 % (CI: 21.1-29.3 %) of patients and 18.0 % (CI: 15.8-20.5 %) of implants. Subgroup analyses revealed significant differences in the prevalence of peri-implant mucositis and peri-implantitis across continents. In non-smokers, the implant-level prevalence of peri-implant mucositis and peri-implantitis was 38.2 % (CI: 33.4-43.2 %) and 5.2 % (CI: 3.6-7.5 %), respectively. The risk of bias was high in 50 %, moderate in 45 %, and low in 5 % of the studies.
CONCLUSIONS: Based on the 2017 World Workshop criteria, the prevalence of peri-implant diseases represents a significant and growing public health challenge. Our study demonstrated that approximately two in three adults with dental implants had peri-implant mucositis, and one in four had peri-implantitis.
CLINICAL SIGNIFICANCE: This study is the first to provide robust global prevalence estimates for peri-implant diseases based on standardized 2017 World Workshop criteria. The findings highlight the high worldwide prevalence of peri-implant diseases, emphasizing the need for uniform diagnostic protocols and targeted prevention and treatment strategies.